Atlas Trials

Triple-negative Metastatic Breast Cancer

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Triple-negative Metastatic Breast Cancer

RecordFirmDate
CISPLATIN + AZD-1775 In Breast Cancer (NCT03012477)Dana-Farber Cancer Institute2017-01-18
Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer (NCT02358200)Pamela Munster2015-02-23
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) (NCT01881230)Celgene2013-09-26
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors (NCT01576666)Novartis Pharmaceuticals2012-07-01
Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer (NCT01069796)ARCAGY/ GINECO GROUP2010-04-01
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel (NCT00516724)AstraZeneca2007-06-22

Track Triple-negative Metastatic Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.